Full-Time

Environmental Health & Safety Coordinator

Clinical and Support Services

Updated on 8/11/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$53k - $75.9k/yr

+ Differentials + Premiums + Bonuses

Boston, MA, USA

In Person

Periodic travel to off-site facilities is required, including for incident response and program support.

Bachelor of Science (BS), Master of Science (MS)

Category
Legal & Compliance (1)
Required Skills
OSHA

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • A Bachelor of Science or equivalent degree in environmental health and safety or a related field is required.
  • Three to five years of experience is required.
  • Knowledge of building engineering systems and trades is required.
  • Experience reading blueprints and floor plans is required.
  • Basic competency in general chemistry is required.
  • Ability to perform tasks while wearing a respirator and other personal protective equipment is required.
  • Ability to read chemical hazard information sources, recognize risks, and apply pertinent safety practices is required.
  • Presentation skills and proficiency in verbal and written English communication are required.
  • Ability to deliver training presentations to varied audiences and audience sizes is required.
  • Ability to interact effectively with individuals and small groups is required.
  • Ability to handle conflict tactfully and constructively is required.
  • Efficient team meeting management and facilitation skills are required.
  • Computer competency with general office software and applications is required.
  • Physical ability to walk, stand, climb, lift, and carry is required.
  • Ability to handle hazardous chemical materials, including spills, is required.
  • Ability to work in environments with biological, chemical, or physical hazards is required.
  • Ability to multitask frequently is required.
  • Ability to perform regular on-call duties and respond to urgent matters during regular and off-hours is required.
  • Ability to travel periodically to off-site facilities is required.
Responsibilities
  • Supervise the Safety and Compliance program within the Environmental Health & Safety department.
  • Support CMS and Joint Commission Life Safety and Environment of Care compliance programs.
  • Coordinate with Clinical, Support Services, Real Estate Facilities, and Engineering departments.
  • Coordinate up to two technical staff.
  • Lead planning and tracking of environmental health, safety, and permitting programs.
  • Standardize programs with the Brigham Health main campus.
  • Lead or participate in safety and compliance program elements affecting patient care, research, and regulatory risk.
  • Identify workplace hazards and safety issues.
  • Develop, implement, and monitor hazard controls and solutions.
  • Assure the continued effectiveness of safety controls through safety-system development and continual process oversight and improvement.
  • Plan, coordinate, and perform general safety functions, including safety surveys, incident investigations, exposure monitoring, hazardous-material management, emergency response support, training, and data and documentation management.
  • Travel to off-site facilities to respond to or investigate incidents and support program needs.
  • Perform scheduled on-call duties and respond to urgent matters with short notice during regular and off-hours.
Desired Qualifications
  • A Master of Science in a health, safety, risk, or public health-related field is preferred.
  • Professional certifications such as Certified Safety Professional, Certified Industrial Hygienist, Certified Hazardous Materials Manager, or Hazardous Materials Emergency Management are preferred.
  • OSHA HAZWOPER certification is preferred.
  • RCRA/DOT certification is preferred.
  • Experience with CMS and Joint Commission codes is preferred.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2025 operating income reached $59 million after a $53 million reorganization charge.
  • Mead Johnson expanded a five-year research partnership with MGB in April 2026.
  • MGB bridge funding keeps NIH-dependent researchers alive through August 2026 deadlines.

What critics are saying

  • Brigham nurses struck July 2026 after a five-day lockout over wages and insurance.
  • MGB closed the Weiner Center, Burn Unit, and iCMP, angering clinicians.
  • Repeated labor conflict and service cuts threaten talent retention and patient trust.

What makes Mass General Brigham unique

  • Mass General Brigham runs nearly $2 billion in research and 3,700 trials.
  • Its 2026 MIT seed program linked 17 translational teams across engineering and care.
  • MGB controls first-look access to discoveries from Harvard-affiliated hospitals and investigators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

Associated Press
May 13th, 2026
Violet Therapeutics raises $4.75M to advance synaptic preservation therapy for neurodegenerative diseases

Violet Therapeutics, a biotechnology company developing therapies for neurodegenerative diseases, has raised $4.75 million in a seed extension round led by Lifespan Vision Ventures. Dementia Discovery Fund, UTEC, Ono Venture Investment and Mass General Brigham Ventures also participated. The Cambridge-based company will use the funding to advance its lead small molecule programme targeting EphB3 through IND-enabling activities. The therapy aims to halt and potentially reverse cognitive decline through glial-mediated synaptic preservation, addressing synaptic loss, the strongest predictor of cognitive decline in Alzheimer's and other neurodegenerative diseases. Violet's proprietary CONNECT platform maps cell-cell interaction networks to identify novel therapeutic targets. Founded by Mass General Brigham Ventures with researchers from Brigham and Women's Hospital, the company is developing first-in-class CNS therapies.

PR Newswire
Apr 23rd, 2026
Brigham nurses to picket as MGB executives earn $35.9M amid service closures and 0% wage offer

Registered nurses at Brigham and Women's Hospital will hold an informational picket on 29 April, protesting Mass General Brigham's corporate decisions affecting patient care and workforce conditions. The Massachusetts Nurses Association represents the nurses, who will demonstrate from 14:00 to 16:00 outside the hospital at 75 Francis Street, Boston. Nurses cite several service closures under MGB, including the Weiner Centre, Burn Unit and Integrated Care Management Programme. They criticise the health system's bargaining proposals, particularly a 0% wage offer for nurses below top step, whilst MGB reported a $59.2 million operating gain in 2025 and paid its top 14 executives $35.9 million in fiscal year 2024. The informational picket will not disrupt patient care, with nurses participating outside working hours.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.